Amneal Pharmaceuticals, Inc. (AMRX)
Healthcare
Drug Manufacturers - Specialty & Generic
18.30 $
-1.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Amneal Pharmaceuticals, Inc. (AMRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -19 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81 | 136 | -4.4 | 40 | 142 | 118 | 7.4 | 84 | 118 | 130 | -29 | -19 | 201 | |
| 57 | 57 | 56 | 63 | 59 | 66 | 60 | 60 | 54 | 49 | 43 | 48 | 194 | |
| 6.7 | 6.0 | 6.7 | 6.7 | 7.1 | 7.2 | 7.3 | 8.3 | 8.2 | 8.2 | 8.8 | 10 | 36 | |
| -35 | 54 | -12 | -117 | 43 | 22 | -106 | -35 | -51 | -12 | -190 | -192 | -445 | |
| 13 | 32 | 20 | 11 | 21 | 23 | 18 | 27 | 15 | 43 | 14 | 46 | 118 | |
| -13 | -32 | -20 | -6.5 | -21 | -16 | -18 | -27 | -22 | -45 | -22 | -123 | -212 | |
| -0.2 | 2.0 | -7.2 | -0.2 | -0.2 | -0.4 | -22 | -0.2 | – | – | – | – | – | |
| – | – | – | – | -87 | -56 | -18 | -16 | 140 | -6.1 | -6.2 | – | – | |
| -87 | -101 | -23 | -35 | -92 | -61 | -39 | -42 | 59 | -10 | -57 | 77 | 70 | |
| -19 | 3.5 | -47 | -2.0 | 29 | 40 | -50 | 15 | 155 | 75 | -109 | -66 | 55 | |
| 68 | 104 | -24 | 29 | 121 | 95 | -11 | 57 | 103 | 87 | -43 | -65 | 83 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.